Perrigo Operating Margin 2010-2025 | PRGO
Current and historical operating margin for Perrigo (PRGO) over the last 10 years. The current operating profit margin for Perrigo as of March 31, 2025 is 9.16%.
| Perrigo Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $4.34B | $0.21B | 4.94% |
| 2024-12-31 | $4.37B | $0.11B | 2.56% |
| 2024-09-30 | $4.39B | $-0.02B | -0.39% |
| 2024-06-30 | $4.43B | $-0.04B | -0.79% |
| 2024-03-31 | $4.56B | $0.05B | 1.08% |
| 2023-12-31 | $4.66B | $0.15B | 3.26% |
| 2023-09-30 | $4.65B | $0.20B | 4.25% |
| 2023-06-30 | $4.63B | $0.17B | 3.65% |
| 2023-03-31 | $4.56B | $0.11B | 2.30% |
| 2022-12-31 | $4.45B | $0.08B | 1.77% |
| 2022-09-30 | $4.40B | $0.10B | 2.16% |
| 2022-06-30 | $4.35B | $0.50B | 11.51% |
| 2022-03-31 | $4.20B | $0.38B | 9.06% |
| 2021-12-31 | $4.14B | $0.41B | 9.91% |
| 2021-09-30 | $4.09B | $0.40B | 9.81% |
| 2021-06-30 | $4.05B | $0.04B | 1.04% |
| 2021-03-31 | $4.02B | $0.23B | 5.75% |
| 2020-12-31 | $4.09B | $0.27B | 6.51% |
| 2020-09-30 | $3.39B | $0.19B | 5.63% |
| 2020-06-30 | $3.58B | $0.17B | 4.64% |
| 2020-03-31 | $3.78B | $0.16B | 4.18% |
| 2019-12-31 | $3.87B | $0.17B | 4.50% |
| 2019-09-30 | $4.71B | $0.32B | 6.77% |
| 2019-06-30 | $4.65B | $0.14B | 3.07% |
| 2019-03-31 | $4.69B | $0.18B | 3.90% |
| 2018-12-31 | $4.73B | $0.24B | 5.01% |
| 2018-09-30 | $4.82B | $0.29B | 5.96% |
| 2018-06-30 | $4.92B | $0.57B | 11.61% |
| 2018-03-31 | $4.97B | $0.63B | 12.58% |
| 2017-12-31 | $4.95B | $0.60B | 12.09% |
| 2017-09-30 | $4.99B | $-0.05B | -0.90% |
| 2017-06-30 | $5.03B | $-1.68B | -33.33% |
| 2017-03-31 | $5.13B | $-1.64B | -31.96% |
| 2016-12-31 | $5.28B | $-2.00B | -37.87% |
| 2016-09-30 | $2.93B | $-2.01B | -68.50% |
| 2016-06-30 | $2.94B | $-0.36B | -12.32% |
| 2015-12-31 | $1.22B | $0.07B | 5.51% |
| 2015-09-30 | $3.31B | $1.63B | 49.18% |
| 2014-12-31 | $3.03B | $1.31B | 43.33% |
| 2014-09-30 | $2.94B | $1.22B | 41.53% |
| 2013-12-31 | $2.83B | $1.34B | 47.25% |
| 2013-09-30 | $2.74B | $1.24B | 45.39% |
| 2012-12-31 | $2.43B | $1.19B | 48.79% |
| 2012-09-30 | $2.39B | $1.14B | 47.82% |
| 2011-12-31 | $2.26B | $1.06B | 47.14% |
| 2011-09-30 | $2.14B | $0.94B | 44.17% |
| 2010-12-31 | $1.90B | $0.92B | 48.44% |
| 2010-09-30 | $1.76B | $0.78B | 44.46% |
| 2009-12-31 | $1.62B | $0.74B | 45.79% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.706B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $215.166B | 25.24 |
| Boston Scientific (BSX) | United States | $153.330B | 38.39 |
| Stryker (SYK) | United States | $148.630B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $131.070B | 0.00 |
| Medtronic (MDT) | Ireland | $114.929B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.764B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.126B | 24.62 |
| ResMed (RMD) | United States | $37.818B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $34.781B | 16.51 |
| Agilent Technologies (A) | United States | $32.381B | 21.11 |
| Terumo (TRUMY) | Japan | $23.911B | 31.06 |
| Koninklijke Philips (PHG) | Netherlands | $23.688B | 16.62 |
| Insulet (PODD) | United States | $20.003B | 78.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.437B | 11.84 |
| Baxter (BAX) | United States | $14.251B | 10.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.214B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.705B | 23.33 |
| Lantheus Holdings (LNTH) | United States | $4.855B | 12.25 |
| Prestige Consumer Healthcare (PBH) | United States | $3.744B | 16.73 |
| Haemonetics (HAE) | United States | $3.485B | 15.88 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.307B | 27.48 |
| ICU Medical (ICUI) | United States | $3.014B | 22.23 |
| LeMaitre Vascular (LMAT) | United States | $1.802B | 40.29 |
| QuidelOrtho (QDEL) | United States | $1.721B | 11.84 |
| AtriCure (ATRC) | United States | $1.449B | 0.00 |
| Acuren (TIC) | United States | $1.408B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Phibro Animal Health (PAHC) | United States | $1.192B | 15.24 |
| Green Thumb Industries (GTBIF) | United States | $1.190B | 26.76 |
| Neogen (NEOG) | United States | $1.029B | 13.17 |
| BioLife Solutions (BLFS) | United States | $0.996B | 0.00 |
| InMode (INMD) | Israel | $0.878B | 8.85 |
| Kestra Medical Technologies (KMTS) | United States | $0.816B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.625B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.619B | 0.00 |
| Owens & Minor (OMI) | United States | $0.599B | 4.97 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| CeriBell (CBLL) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.557B | 0.00 |
| Surmodics (SRDX) | United States | $0.432B | 0.00 |
| SNDL (SNDL) | Canada | $0.405B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.314B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.298B | 10.97 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.267B | 0.00 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.63 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.50 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.235B | 10.68 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Brainsway (BWAY) | Israel | $0.228B | 60.45 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Canopy Growth (CGC) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.199B | 0.00 |
| Omeros (OMER) | United States | $0.197B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.149B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.73 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.80 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.52 |
| Nephros (NEPH) | United States | $0.039B | 52.07 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |